CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity & Safety Study in Preterm & Full-term Infants of GSK Biologicals' Hib-MenC Vaccine, Menitorix™ Co-administered With Infanrix™ Penta & Prevenar™ at 2, 4, 6 Months & as a Booster With Infanrix™ IPV & Prevenar™ at 16-18 Months

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00586612
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:49.493341+00:00
Published At: 2010-01-22T00:00:00+00:00
Record Updated At: 2018-08-27
Results Posted At: 2010-01-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Haemophilus Influenzae Type b", "Neisseria Meningitidis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-27"
protocolSection.identificationModule.nctId: "NCT00586612"
protocolSection.identificationModule.officialTitle: "Immunogenicity \u0026 Safety Study in Preterm \u0026 Full-term Infants of GSK Biologicals\u0027 Hib-MenC Vaccine, Menitorix\u2122 Co-administered With Infanrix\u2122 Penta \u0026 Prevenar\u2122 at 2, 4, 6 Months \u0026 as a Booster With Infanrix\u2122 IPV \u0026 Prevenar\u2122 at 16-18 Months"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2010-01-22"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.